The last two years have witnessed a sudden upsurge in the need for pharmaceutical and biotechnical supplies.
Along with Covid-19 infecting millions of people worldwide, came an overwhelming demand for medicines, vaccinations, hospital equipment, healthcare supplies, and facilities.
The overnight conversion of more properties into treatment wards for infected Covid-19 patients highlighted the importance of pharma and biotech on a global scale.
Although the need for these supplies cannot be overlooked, another industry was simultaneously on the rise : the global pharmaceutical and biotechnology environment monitoring market.
What is environmental monitoring?
Environmental monitoring refers to recording and interpreting a range of temperature, pressure, air quality, and humidity conditions. It includes measures and tools to observe environmental conditions and trends to form and implement policies that guide experts and individuals associated with the environment.
Data loggers are among the most prevalent tools used by most industries for environmental monitoring. These automated devices have sensors that can accurately measure and record temperatures that scale to extreme ranges. This ability of data loggers is causing many research and academic institutions to use the device.
Environmental monitoring is essential to ensure that the subjected material is met with viable conditions to sustain its quality. Numerous industries like food manufacturing, automobiles, fashion, and pharmaceutical companies use environmental monitoring to provide an adequate environment for their storage, manufacturing, and shipping processes.
How is environmental monitoring used in the pharma industry?
With pharmaceutical and biotech industries witnessing a boom, there is a need to formulate facilities and sketch a dynamic mechanism to sustain their products. This is where environmental monitoring steps in and carries the responsibility.
Environmental monitoring is essential at all steps of pharmaceutical and biopharmaceutical production. It ensures the safety of the manufactured drugs. It provides a controlled environment for regulating the contaminants, viable organisms, and non-viable particles. In the case of aseptic manufacturing processes, more extensive mechanisms for environmental monitoring are considered. Global companies that operate from multiple production facilities require a rigorous approach to the monitoring process and include numerous data recordings, assessments, and rounds of study.
The pharmaceutical industry deals with drugs, vaccines, and other products susceptible to environmental conditions like temperature and humidity. It therefore becomes essential for that industry to arrange for accurate environmental monitoring.
A recent example of the association between pharmaceutical and environmental monitoring can be found in the constantly growing requirements for cold storage facilities to store Covid-19 vaccines. Dickson states that pharmacies, hospitals, and other healthcare units responsible for storing and administering vaccines arranged for cold storage chains equipped with high-quality tools to sustain the potency of the Covid-19 vaccine vials throughout transport and storage.
The vaccines require extreme freezing temperature conditions. Any deviation from the prescribed range would spoil the entire shipment. In times as critical as the pandemic where every single dose counts, the loss of thousands of vaccines can cause chaos and reduce the gap between the well-being of people and Covid-19 infection.
The Pharmaceutical Environmental Monitoring Market report by MarketWatch assesses the pharmaceutical and biotechnology environmental monitoring market. It highlights other constituents that account for the growing trends of the industry. The report also observes different pharmaceutical and biotechnology environmental monitoring components, including the required equipment, services, media, kits, and reagents.
The CDC has also given clear instructions for storing vaccines and addressed environmental monitoring facilities as a critical component from manufacturing to shipment and storage.
Top Players of the Pharmaceutical and Biotechnology Environmental Monitoring market
Like any other industry with a superb market value, the pharmaceutical and biotechnology environmental monitoring industry also witnesses neck-to-neck competition. Thermo Fisher Scientific, Danaher Corporation and Merck KGAA make it to the list of the top three accounts that constitute 20% of the market. Other top players include Lonza and Eurofins, recognized as the leading producers of the market.
North America accounts for 40% of the entire market. It has the strongest hold on the industry on a global scale. Europe follows North America and covers 25% of the market.
Why has monitoring grown in companies, industries, regions, and applications?
The remarkable growth in the pharmaceutical and biotechnology environmental monitoring industry directly correlates to the increasing demands for healthcare facilities, disease detection and prevention operations, updated industry standards, and changing economic fundamentals of nations worldwide.
The research report about the pharmaceutical, environmental monitoring market by MarketWatch reveals the objectives and missions businesses have opted to use in the current global settings to accelerate their growth. The competitive angle of the industry has led to numerous upgrades, which in turn have created a broader pitch for a variety of products and facilities. The array further opens up the avenues to pharmaceutical and healthcare units with distinct capacities in terms of facility, requirement, and finances.
Leading brands from the industry are enhancing their product portfolio and market strategy with a more customer-centric company profile and cost structure. The enhanced market strategies are accountable for brand development and market consolidation, resulting in higher acquisition.
Ho is it expected to grow through the next five years?
The market analysis and insights of the global pharmaceutical and biotechnology environmental monitoring market showcase bright prospects.
The growth trajectory of the pharma and biotech environmental monitoring market shows a remarkably progressive stride. It was valued at a splendid figure of US $13.86 billion in 2020, and the forecast expects it to rise with a CAGR (Compound Annual Growth Rate) of 4.1% from 2021 to 2025.
The monitoring technologies in this industry are getting smarter by the day, and many more companies are coming up with products that are faster and wiser, addressing various important data points required in the monitoring process. These upcoming developments in the industry will also open more investment opportunities that will strengthen the market base and add to the pharmaceutical and biotechnology environmental monitoring market trends.
Keeping all of the above factors in mind, one can expect the pharmaceutical and biotech environmental monitoring industry to continue to have an upward trend through 2027.